Whitehawk Therapeutics, Inc. 00032Q104 06/11/2026 To approve, on an advisory basis, the compensation of the named executive officers SECTION 14A SAY-ON-PAY VOTES 591179 0 AGAINST 591179 FOR Whitehawk Therapeutics, Inc. 00032Q105 06/11/2026 To approve, on an advisory basis, the compensation of the named executive officers SECTION 14A SAY-ON-PAY VOTES 548184 0 AGAINST 548184 FOR VYNE Therapeutics Inc. 92941V407 12/12/2025 To approve, on an advisory basis, the compensation of the named executive officers SECTION 14A SAY-ON-PAY VOTES 168598 0 AGAINST 168598 FOR VYNE Therapeutics Inc. 92941V407 12/12/2025 To approve, on an advisory basis, the compensation of the named executive officers SECTION 14A SAY-ON-PAY VOTES 232827 0 AGAINST 232827 FOR Urogen Pharma Ltd M96088105 06/22/2026 Approve amendment to Compensation Policy (D&O insurance) COMPENSATION 702837 0 FOR 702837 FOR Urogen Pharma Ltd M96088105 06/22/2026 To approve, on an advisory basis, the compensation of named executive officers SECTION 14A SAY-ON-PAY VOTES 702837 0 FOR 702837 FOR Puma Biotechnology, Inc. 74587V107 06/11/2026 Advisory vote to approve compensation of named executive officers SECTION 14A SAY-ON-PAY VOTES 2393152 0 AGAINST 2393152 FOR Puma Biotechnology, Inc. 74587V107 06/11/2026 Advisory vote to approve compensation of named executive officers SECTION 14A SAY-ON-PAY VOTES 1738147 0 AGAINST 1738147 FOR Cardiff Oncology, Inc. 14147L108 06/11/2026 Proposal to approve, on an advisory basis, executive compensation SECTION 14A SAY-ON-PAY VOTES 1062084 0 FOR 1062084 FOR